• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • Acceptance and Examination of Chemical APIs – Trial Guidelines (Draft) Issued

Acceptance and Examination of Chemical APIs – Trial Guidelines (Draft) Issued

Acceptance and Examination of Chemical APIs
Saturday, 26 February 2022 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

Acceptance and Examination of Chemical APIs – Trial Guidelines (Draft) Issued

Acceptance and examination of chemical APIs trial guidelines have had its first draft issued in April 2020. The trial guideline is expected to be finalized and come into effect soon. The guideline will improve the precision in preparing the dossier and reduce the time needed for the application.

On February 8, 2022, the CDE (Centre for Drug Evaluation) issued the second draft to supplement the Administrative Measures for Drug Registration (No.27-2020).

Highlights – Acceptance and examination of chemical APIs

  • The scope is adjusted to be applicable for the registration of APIs only.
  • Added supporting document requirements in terms of product design validation, product registration number, etc.
  • Standardized format and size of the CD-Rom for submission and facilitation of data management.

By Yu Fang and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Active Pharmaceutical Ingredients, API, drug, pharmaceuticals

What you can read next

Working Procedures for Medical Device Quality Spot Inspections in China
China medical device registration review requirements
China medical device registration review requirements updates in September 2022 by NMPA
China drug standards draft measures
China drug standards draft measures have been published by the NMPA

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.